Theravance Biopharma, Inc. (TBPH)
16.10
+0.08
(+0.50%)
USD |
NASDAQ |
Apr 06, 16:00
16.10
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Total Liabilities (Quarterly) : 188.85M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Integer Holdings Corp. | 1.664B |
| QuidelOrtho Corp. | 3.849B |
| Catalyst Pharmaceuticals, Inc. | 152.54M |
| Viatris, Inc. | 22.48B |
| Nektar Therapeutics | 190.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 485.57M |
| Shareholders Equity (Quarterly) | 296.72M |
| Debt to Equity Ratio | 0.2544 |
| Current Ratio | 10.93 |
| Net Debt Paydown Yield | -0.64% |